Phase I Clinical Study of HY01 in Patients

Clinical trial NCT04961099 · UNKNOWN

Trial details

NCT number: NCT04961099
Sponsor: Heyu (Suzhou) Pharmaceutical Technology Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Sudden Sensorineural Hearing Loss

Start date: 2021-06-23
Primary completion: 2021-10-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.